MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Defining biomarkers to discriminate between organic and functional dystonia

A. Stephan, D. Benninger (Lausanne, Switzerland)

Meeting: 2019 International Congress

Abstract Number: 1344

Keywords: Cerebellum, Psychogenic movement disorders(PMD): Pathophysiology, Transcranial magnetic stimulation(TMS)

Session Information

Date: Tuesday, September 24, 2019

Session Title: Dystonia

Session Time: 1:45pm-3:15pm

Location: Les Muses Terrace, Level 3

Objective: Establish methodologies, fast and easy to translate to clinics, that help discriminate between organic and functional dystonia.

Background: Functional dystonias are challenging diagnoses that are thought to be linked to psychological causes, although their pathophysiology remains unknown. There is a need to find reliable measurable differences between the two populations to support the difficult differential diagnosis.

Method: The techniques we used in this study with patients with established organic and functional dystonia were chosen because they have both potential to differentiate between the two populations based on literature, and are easy to translate to clinical use if they can discriminate between patients. We targeted the primary motor cortex (M1) and the cerebellum.To investigate excitability, inhibition and plasticity of M1 we used a fast alternative to the classical paired associative stimulation (PAS). PAS is a transcranial magnetic stimulation paradigm that repeatedly pairs a peripheral nerve stimulation with a TMS primary motor cortex (M1) pulse to induce hebbian-like plasticity. After confirming that a 2 minutes 5Hz protocol could induce a facilitation comparable to the classical 20 minutes 0.2Hz protocol in a cross-over study with healthy subject we used it to evaluate plasticity in patients.The eyeblink classical conditioning (EBCC), a well-documented form of cerebellar dependent learning paradigm, was used for non-invasive cerebellar activity investigation. In an effort to automate and ameliorate response detection, we used machine learning to automatically detect eyeblink in an unbiased and fast process.

Results: Patients with organic and functional dystonia all demonstrated significant altered M1 and cerebellar function in comparison to healthy age-matched volunteers. The number of patients with functional dystonia recruited is currently too low to process separately from patients with organic form. Analyses comparing the two populations will be included in the poster after further recordings.

Conclusion: PAS and EBCC are two promising clinical tools to help discriminate between organic and functional movement disorders. Both protocoles can be influenced by variables such as age or limb immobility, it is thus necessary to record enough patients to allow regression analysis and a definition of normal range of reponse considering all pertinent factors.

To cite this abstract in AMA style:

A. Stephan, D. Benninger. Defining biomarkers to discriminate between organic and functional dystonia [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/defining-biomarkers-to-discriminate-between-organic-and-functional-dystonia/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/defining-biomarkers-to-discriminate-between-organic-and-functional-dystonia/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley